DIA Bioventure Day

Is the current Bioventure paradigm delivering return for patients and investors? This is the key question to be addressed by stakeholders from the funding, and from the innovating side.

Agenda

Day 1 Mar 28, 2017

8:30 AM — 8:50 AM Welcome remarks
8:50 AM — 9:10 AM Key Note: Success Factors for Bringing a Product to the Market
9:10 AM — 10:40 AM Session 1: Health System Financing and Reimbursement of Innovation
11:00 AM — 12:30 PM Session 2: Innovative Funding Models
12:30 PM — 1:15 PM EMA Health Care Pipeline White Spots Analysis – Opportunities for BioVentures?
2:00 PM — 3:30 PM Hepatitis C: Expensive Cure Versus Life-Long Suffering and Health Care Expenses
4:00 PM — 5:30 PM Immuno-Oncology: Therapeutic Break Through Area or Nightmare for Health Care Funding
5:30 PM — 7:30 PM Moderated Poster Walk & Networking Reception

Contact us

Registration Questions

Send Email
+41 61 225 51 51

Agenda and Logistics

Send Email
+41 61 225 51 49

DIA Bioventure Day

Agenda

Day 1 Mar 28, 2017

Contact us

Registration Questions

Agenda and Logistics

Be informed and stay engaged.